Tocagen Inc (TOCA) Stock Price & Overview

NASDAQ:TOCA

Current stock price

1.26
-0.05 (-3.82%)
At close:
1.32
+0.06 (+4.76%)
After Hours:

The current stock price of TOCA is 1.26 null. Today TOCA is down by -3.82%. In the past month the price increased by 6.78%. In the past year, price decreased by -79.24%.

TOCA Key Statistics

52-Week Range0.422 - 6.77
Current TOCA stock price positioned within its 52-week range.
1-Month Range1.15 - 1.87
Current TOCA stock price positioned within its 1-month range.
Market Cap
30.138M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-2.69
Dividend Yield
N/A

TOCA Stock Performance

Today
-3.82%
1 Week
-10.64%
1 Month
+6.78%
3 Months
-11.27%
Longer-term
6 Months +143.29%
1 Year -79.24%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

TOCA Stock Chart

Tocagen Inc / TOCA Daily stock chart

TOCA Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to TOCA. When comparing the yearly performance of all stocks, TOCA is a bad performer in the overall market: 98.05% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

TOCA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to TOCA. TOCA has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TOCA Earnings

Next Earnings DateN/A
Last Earnings DateN/A

TOCA Forecast & Estimates


Analysts
Analysts60
Price TargetN/A
EPS Next Y1.49%
Revenue Next YearN/A

TOCA Financial Highlights

Over the last trailing twelve months TOCA reported a non-GAAP Earnings per Share(EPS) of -2.69. The EPS decreased by -10.25% compared to the year before.


Income Statements
Revenue(TTM)27.00K
Net Income(TTM)-56.71M
Industry RankSector Rank
PM (TTM) -210044.44%
ROA -304.38%
ROE N/A
Debt/Equity 1.88
Chartmill High Growth Momentum
EPS Q2Q%54.17%
Sales Q2Q%-100%
EPS 1Y (TTM)-10.25%
Revenue 1Y (TTM)-99.85%

TOCA Ownership

Ownership
Inst Owners21.42%
Shares23.92M
Float19.86M
Ins Owners2.09%
Short Float %N/A
Short RatioN/A

About TOCA

Company Profile

Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company which focuses on retroviral gene therapy platforms. The company's lead product candidate consists of Toca 511 & Toca FC, initially for the treatment of recurrent high grade glioma, a disease with a significant unmet medical need. Tocagen, Inc. is based in San Diego, United States.

Company Info

Tocagen Inc

4242 CAMPUS POINT COURT SUITE 500

SAN DIEGO CA 92121

CEO: Martin J. Duvall

Phone: 858-412-8400

Tocagen Inc / TOCA FAQ

What does Tocagen Inc do?

Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company which focuses on retroviral gene therapy platforms. The company's lead product candidate consists of Toca 511 & Toca FC, initially for the treatment of recurrent high grade glioma, a disease with a significant unmet medical need. Tocagen, Inc. is based in San Diego, United States.


Can you provide the latest stock price for Tocagen Inc?

The current stock price of TOCA is 1.26 null. The price decreased by -3.82% in the last trading session.


What is the dividend status of Tocagen Inc?

TOCA does not pay a dividend.


What is the ChartMill technical and fundamental rating of TOCA stock?

TOCA has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Can you provide the market cap for Tocagen Inc?

Tocagen Inc (TOCA) has a market capitalization of 30.14M null. This makes TOCA a Nano Cap stock.